Navigation Links
QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
Date:2/10/2010

tly available to the management of QRxPharma.  Forward-looking statements therefore speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.

By their very nature, forward-looking statements involve risks and uncertainties.  A number of important factors could therefore cause actual results to differ materially from those contained in any forward-looking statement.  Such factors include risks relating to the stage of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialisation of the Company's proposed products.

About QRxPharma

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders.  Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma's product portfolio includes both late and early stage clinical drug candidates with well-defined paths to regulatory approval and sales. The Company intends to directly commercialise its products in the US and seek strategic partnerships for worldwide markets.

QRxPharma's lead compound, MoxDuo™IR (Q8003IR), is in Phase 3 clinical development

and has successfully completed multiple comparative studies evaluating its efficacy and safety

against equianalgesic doses of morphine, oxycodone and Percocet® for the treatment of acute pain. Study results consistently demonstrate MoxDuo™IR's greater overall tolerability, achieving as good or better pain relief with substantially fewer incidences of moderate to severe side effects. The Company's preclinical and clinical pipeline includes other tec
'/>"/>

SOURCE QRxPharma Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Inventor of ProTide technology ...   NuCana, a clinical stage biopharmaceutical company ... portfolio of novel anti-cancer medicines, today announced the appointment ... Officer. Professor McGuigan was the original inventor ... Medicinal Chemistry at the Cardiff School of Pharmacy and ...
(Date:6/30/2015)... BRUSSELS , July 1, 2015 ... proud to announce the winners of the first Ansell ... European Operating Room (O.R.) Nurses. The 2015 award, organised ... (EORNA), recognizes perioperative nurses who display exceptional skill and ... to staff education and development. Award ceremonies are taking ...
(Date:6/30/2015)... , June 30, 2015  The MEDevice San ... year, is an event dedicated to bringing medtech professionals ... issues and topics affecting the industry today. This year,s ... the challenges and opportunities facing today,s medtech professional in ... and to register for MEDevice San Diego, please visit: ...
Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... eastern, Persian and Mediterranean foods and groceries. Persianbazzar.com has recently announced that their ... BBQ season, http://persianbazzar.com added great product lines such as BBQ skewers, ...
(Date:6/30/2015)... ... ... Avid boxing style rock concert poster collector, Andrew Hawley from Vintage Rock ... and the Rascals also played at this concert in New York City. The concert ... Who backing them up. The Doors gave a very stirring performance on a hot ...
(Date:6/30/2015)... ... June 30, 2015 , ... As 1Heart Caregiver Services® ... as a Master Franchisor. 1Heart Caregiver Services® welcomed its next Franchisee, 1Heart Caregiver ... Ambassadors headed by Keith Mashburn, Pam Campeau, field representative of the California State ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... In the ... The snowpack in the Sierra Nevada mountains measured zero for the first time ... in the midst of one of its most sustained periods of increasing drought.” ...
(Date:6/30/2015)... ... July 01, 2015 , ... Carey Danis & ... being managed in a West Virginia federal court. The court document outlined the ... date for the 26 cases.¹ , Carey Danis & Lowe is a personal injury ...
Breaking Medicine News(10 mins):Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 3Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 3Health News:1Heart Caregiver Services® Simi Valley Grand Opening 4Health News:RainSoil launches water-retention product as drought spreads. 2Health News:RainSoil launches water-retention product as drought spreads. 3Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3
... epidemic has entered a disturbing new phase, with a study ... the sharp rise in the number of cases. , A ... South Wales (UNSW), believe this emerging new genotype (called ... evading the protective effects of the current acellular vaccine (ACV), ...
... Arabic have more challenges reading in Arabic than native Hebrew ... two halves of the brain divide the labor differently when ... English. That is the result of a new study conducted ... the Edmond J. Safra Brain Research Center for the Study ...
... of anesthesia providers to monitor sedation during screening colonoscopies ... 2003 to 2009 in the United States, with most ... need this service, according to a new RAND Corporation ... $1.1 billion spent annually on anesthesia services for GI-related ...
... Austria: New research has shown for the first time that ... oestrogen receptor positive breast cancer to become pregnant, despite doctors, ... the body and cause the cancer to return. In ... eighth European Breast Cancer Conference (EBCC-8) in Vienna, suggest that ...
... TUESDAY, March 20 (HealthDay News) -- Calculating the ... and right arms might help predict a patient,s odds ... Researchers found that people with high blood pressure ... at higher risk of cardiovascular death over 10 years. ...
... a consortium of investigators from 13 countries led the University ... Catholic University of Leuven, Belgium in Europe, found that nurses ... of leaving also had patients who were more satisfied with ... study was released today in the current issue of the ...
Cached Medicine News:Health News:Sharp rise in cases of new strain of whooping cough 2Health News:Sharp rise in cases of new strain of whooping cough 3Health News:Brain's involvement in processing depends on language's graphic symbols 2Health News:Brain's involvement in processing depends on language's graphic symbols 3Health News:Use of anesthesia providers during GI procedures is growing, but may be unnecessary 2Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 2Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 3Health News:Pregnancy is safe for women with estrogen receptor positive breast cancer 4Health News:Blood Pressure Variance Between Arms Points to Heart Risk 2Health News:International research finds quality and safety problems in hospitals throughout 13 countries 2
For the quantitative determination of uric acid in serum....
For determination of uric acid in serum, plasma or urine. For Hitachi 704 / 911. Available with Calibrator: Trucal U and controls: Trulab N and Trulab P....
For the quantitative determination of uric acid in serum....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
Medicine Products: